← Leaderboards
Ronald J Weigel
Stanford University
$9,256,561
Attributed
$10,913,377
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,913,377 · 6
By mechanism
R01$7,078,458 · 5
T32$3,834,919 · 1
Top collaborators
- Songhai Chen7 shared
Most similar at Stanford University
Same institution · by research overlap
- Anthony E Oro$25,372,453
- Ralph Rabkin$998,349
- David Feldman$8,560,053
- Shirit Einav$7,596,823
- Gerald R. Crabtree$18,872,595
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsResponseMediatingMalignant Breast NeoplasmOverexpressionBreast Cancer CellIowaTumor GrowthTumorigenesisTumorUniversitiesEffectivenessNew Therapeutic TargetGenetic TranscriptionClinically RelevantProteinsResistanceEpigenetic ProcessSurgical OncologyMolecularBaseGenesIn VitroEstrogen Receptor Alpha
Grant awards (32)
Role of the CTLH E3 ubiquitin ligase in breast cancer progression$497,084
R01 · FY2025 · CA
Role of the CTLH E3 ubiquitin ligase in breast cancer progression$497,084
R01 · FY2024 · CA
Role of Gi/o-GPCR signaling in breast cancer progression$466,693
R01 · FY2021 · CA
Role of Gi/o-GPCR signaling in breast cancer progression$466,693
R01 · FY2020 · CA
University of Iowa Surgical Oncology Training Grant$413,722
T32 · FY2020 · CA · contact PI
Role of Gi/o-GPCR signaling in breast cancer progression$452,692
R01 · FY2019 · CA
University of Iowa Surgical Oncology Training Grant$428,530
T32 · FY2019 · CA · contact PI
RET as a novel therapeutic target for breast cancer$335,050
R01 · FY2019 · CA · contact PI
Role of Gi/o-GPCR signaling in breast cancer progression$466,693
R01 · FY2018 · CA
University of Iowa Surgical Oncology Training Grant$420,203
T32 · FY2018 · CA · contact PI
RET as a novel therapeutic target for breast cancer$345,413
R01 · FY2018 · CA · contact PI
Role of Gi/o-GPCR signaling in breast cancer progression$466,693
R01 · FY2017 · CA
University of Iowa Surgical Oncology Training Grant$422,785
T32 · FY2017 · CA · contact PI
RET as a novel therapeutic target for breast cancer$345,413
R01 · FY2017 · CA · contact PI
University of Iowa Surgical Oncology Training Grant$417,912
T32 · FY2016 · CA · contact PI
RET as a novel therapeutic target for breast cancer$345,413
R01 · FY2016 · CA · contact PI
RET as a novel therapeutic target for breast cancer$345,413
R01 · FY2015 · CA · contact PI
University of Iowa Surgical Oncology Research Training Program$382,428
T32 · FY2014 · CA · contact PI
University of Iowa Surgical Oncology Research Training Program$357,902
T32 · FY2013 · CA · contact PI
University of Iowa Surgical Oncology Research Training Program$62,075
T32 · FY2013 · CA · contact PI
University of Iowa Surgical Oncology Research Training Program$366,368
T32 · FY2012 · CA · contact PI
University of Iowa Surgical Oncology Research Training Program$374,474
T32 · FY2011 · CA · contact PI
MECHANISMS OF ESTROGEN RECEPTOR REGULATION$231,383
R01 · FY2010 · CA · contact PI
University of Iowa Surgical Oncology Research Training Program$188,520
T32 · FY2010 · CA · contact PI
MECHANISMS OF ESTROGEN RECEPTOR REGULATION$231,383
R01 · FY2009 · CA · contact PI
MECHANISMS OF ESTROGEN RECEPTOR REGULATION$231,383
R01 · FY2008 · CA · contact PI
MECHANISMS OF ESTROGEN RECEPTOR REGULATION$231,383
R01 · FY2007 · CA · contact PI
MECHANISMS OF ESTROGEN RECEPTOR REGULATION$250,347
R01 · FY2006 · CA · contact PI
ESTROGEN RECEPTOR CONTROL AND FUNCTION IN BREAST CANCER$281,374
R01 · FY2001 · CA
ESTROGEN RECEPTOR CONTROL AND FUNCTION IN BREAST CANCER$88,650
R01 · FY2001 · CA
ESTROGEN RECEPTOR CONTROL AND FUNCTION IN BREAST CANCER$84,760
R01 · FY2001 · CA
ESTROGEN RECEPTOR CONTROL AND FUNCTION IN BREAST CANCER$417,461
R01 · FY2000 · CA